ARBOR EQUITY GROUP FUND I, LP

EUGENE, OR · Founded 2023 · CIK 0001994989 · Biotech

Programmable DNA editors for genetic medicine development

arbor.bio →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$500K
1 Form D · Oct 2023
36 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$500,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2119DFI Holding Inc.—$55M
2120Sonoma Biotherapeutics—$265M
2121ARVINAS, INC.—$129M
2122ARBOR EQUITY GROUP FUND I, LP—$500K
2123Indapta Therapeutics Inc.—$84M
2124PERIOMICS CARE LLC——
2125Apricity Therapeutics——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 4 related persons
  • ARBOR GROUP LLCPromoter
  • JARED HICKSPromoter
  • MICHAEL PROULXPromoter
  • RYAN STRASSHOFERPromoter

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.